Health Care & Life Sciences » Biotechnology | Proteome Sciences PLC

Proteome Sciences PLC

Proteome Sciences PLC
Stock Exchange Other OTC
EPS
$0.01
Market Cap
$20.66 M
Shares Outstanding
295.18 M
Public Float
-
Proteome Sciences PLC
Stock Exchange London Stock Exchange
EPS
GBP0.01
Market Cap
GBP11.22 M
Shares Outstanding
295.18 M
Public Float
236.32 M

Profile

Address
Hamilton House
London Greater London WC1H 9BB
United Kingdom
Employees -
Website http://proteomics.com
Updated 07/08/2019
Proteome Sciences Plc is engaged in applied proteomics and peptidomics services and applications. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection.

Financials

View All
Created with Highcharts 5.0.14Proteome Sciences PLCNet Income. Fiscal year is January-December. All values GBP Thousands.3 1493 1493 5663 5662 7182 7182 2802 2802 4972 4971 3131 31320132014201520162017201801k2k3k4k
Created with Highcharts 5.0.14Proteome Sciences PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.2 1362 1361 5601 5601 8821 8822 7442 7443 3803 3803 0493 04920132014201520162017201801k2k3k4k

Christopher D. J. Pearce
Non-Executive Chairman
Jeremy Rupert Michael Haigh
Chief Executive Officer & Executive Director